Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Clinical Trial

Research Support, Non-U.S. Gov't

Comparative Study

Multicenter Study

Meta-Analysis

Systematic Review

Controlled Clinical Trial

Clinical Trial, Phase II

Clinical Trial, Phase III

Letter

Review

Clinical Trial, Phase I

Publication Year

From

Quick links

Individual year

2024

2023

2022

2021

2019

2017

2014

2013

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Norethindrone Acetate""[mesh_terms]

56 Results

Searching titles within these results

The effect of 17beta-estradiol plus norethisterone acetate on anthropometric indices: A systematic review and meta-analysis of randomized controlled trials.

Yushan Li, Xiao Chen, Xingji Gong, Dongyong He, Xi Cheng, Kousalya Prabahar, Benjamin Hernández-Wolters, Periyannan Velu, Wenjie Du

European journal of obstetrics, gynecology, and reproductive biology 2023;287():176-185

Full Text

Abstract

The effect of transdermal 17β-estradiol combined with norethisterone acetate treatment on the lipid profile in postmenopausal women: A meta-analysis and systematic review of randomized controlled trials.

Wenjuan Tao, Xiangying Cai, Mohammad Khaldoun Al Masri, Mihnea-Alexandru Găman, Kousalya Prabahar, Saeed Baradwan, Peijun Mao

Steroids 2022;185():109061

Full Text

Abstract

Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.

Juliawati Muhammad, Yusnita Yusof, Imran Ahmad, Mohd Noor Norhayati

BMC women's health 2022;22(1):14

Free Full Text

Abstract

The effect of 17β-estradiol plus norethisterone acetate treatment on the lipid profile in women: a dose-response meta-analysis of randomized controlled trials.

Ahmed Abu-Zaid, Mihnea-Alexandru Gaman, Parsa Jamilian, Bolaji Lilian Ilesanmi-Oyelere, Parmida Jamilian, Saeed Baradwan, Juhaina S Bajaman, Kamar Allayl Alras, Emad Kutbi, Ahmed Khalid Maher Al-Ghrairi, Dalya Dhia Sadulah Sadulah, Ebraheem Albazee, Osama Alomar, Ismail A Al-Badawi, Hany Salem

Experimental gerontology 2022;165():111855

Full Text

Abstract

National differences in lipid response to postmenopausal hormone replacement therapy.

Olavi Ylikorkala, Varpu Ranta, Hanna Oksanen, Stefan Arrenbrecht

Maturitas 2002;42(4):259-65

Full Text

Abstract

The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.

Javier Molina, Joaquin Calaf, Antonio Cano

Archives of gynecology and obstetrics 2004;268(4):317-22

Full Text

Abstract

Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.

Ian F Godsland, Payal Trupti Kotecha, David Crook, John C Stevenson

Clinical endocrinology 2021;92(4):303-311

Full Text

Abstract

Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.

Göran Samsioe, Cairu Li, Christer Borgfeldt, Kittisak Wilawan, Anders Aberg, Sören Larsen

Menopause (New York, N.Y.) 2003;9(5):335-42

Full Text

Abstract

The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.

Rosario D'Anna, Giovanni Baviera, Francesco Corrado, Francesco Cancellieri, Alessandra Crisafulli, Francesco Squadrito

Acta obstetricia et gynecologica Scandinavica 2005;84(5):474-7

Free Full Text

Abstract

Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.

O Ylikorkala, P Lim, P Caubel

Clinical therapeutics 2000;22(5):622-36

Full Text

Abstract

Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.

Semih Tugrul, Gazi Yildirim, Oya Pekin, Hüsamettin Uslu, Tayfun Kutlu, Sadiye Eren

Archives of gynecology and obstetrics 2007;275(5):335-9

Full Text

Abstract

Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.

Erik Qvigstad, Odd Erik Johansen

Advances in therapy 2009;25(6):525-51

Full Text

Abstract

Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.

M Dören, A Rübig, H J Coelingh Bennink, W Holzgreve

American journal of obstetrics and gynecology 2000;183(3):575-82

Full Text

Abstract

Combined hormone replacement therapy improves lipids but may increase leucocytes.

H Bergstrøm, S Tonstad

Journal of internal medicine 2006;259(5):537-8

Free Full Text

Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women.

G Labos, E Trakakis, P Pliatsika, A Augoulea, V Vaggopoulos, G Basios, G Simeonidis, M Creatsa, A Alexandrou, Z Iliodromiti, D Kassanos, I Lambrinoudaki

Journal of endocrinological investigation 2014;36(7):521-6

Full Text

Abstract

Results: 1 – 15 / 56

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Norethindrone Acetate""[mesh_terms]

The effect of 17beta-estradiol plus norethisterone acetate on anthropometric indices: A systematic review and meta-analysis of randomized controlled trials.

The effect of transdermal 17β-estradiol combined with norethisterone acetate treatment on the lipid profile in postmenopausal women: A meta-analysis and systematic review of randomized controlled trials.

Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.

The effect of 17β-estradiol plus norethisterone acetate treatment on the lipid profile in women: a dose-response meta-analysis of randomized controlled trials.

National differences in lipid response to postmenopausal hormone replacement therapy.

The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.

Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.

Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.

The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.

Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.

Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.

Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.

Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.

Combined hormone replacement therapy improves lipids but may increase leucocytes.

Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women.

Results for
""Norethindrone Acetate""[mesh_terms]